Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
ClinicalTrials.gov study NCT05556616. IPD Sharing: YES. Countries: 4. Publications: 0.
A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.
ClinicalTrials.gov study NCT02164955. IPD Sharing: Not stated. Countries: 8. Publications: 3.
Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074)
ClinicalTrials.gov study NCT00642954. IPD Sharing: YES. Countries: 0. Publications: 1.
The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma
ClinicalTrials.gov study NCT00207805. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)
ClinicalTrials.gov study NCT01745640. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients
ClinicalTrials.gov study NCT01010880. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rituximab in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00003554. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to Lenalidomide
ClinicalTrials.gov study NCT01166113. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma
ClinicalTrials.gov study NCT03695744. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
ClinicalTrials.gov study NCT01665014. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00002878. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Busulfan and Melphalan Conditioning in Multiple Myeloma
ClinicalTrials.gov study NCT01923935. IPD Sharing: Not stated. Countries: 1. Publications: 32.
Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse
ClinicalTrials.gov study NCT01087008. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)
ClinicalTrials.gov study NCT04196491. IPD Sharing: YES. Countries: 1. Publications: 1.
Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma
ClinicalTrials.gov study NCT00396045. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.
ClinicalTrials.gov study NCT04309981. IPD Sharing: NO. Countries: 1. Publications: 3.
Stem Cell Transplantation for Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01526096. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
ClinicalTrials.gov study NCT00002630. IPD Sharing: Not stated. Countries: 1. Publications: 8.
A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT05860036. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04083898. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.